Physician profile
Sonia Kaur Panesar
NPI 1578756383
$558.29
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $79.69 · 2021: $89.10 · 2022: $19.94 · 2024: $45.10 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $103.17 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $79.28 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $62.81 | 2019-2020 | |
| Astellas Pharma US INC | $53.90 | 2025 | Veozah |
| Smith+Nephew, INC. | $43.04 | 2021-2025 | Pico |
| Daiichi Sankyo INC. | $36.15 | 2021 | |
| Organon LLC | $35.31 | 2024-2025 | Jada System |
| Sage Therapeutics, LLC | $28.81 | 2024 | |
| Coopersurgical, INC. | $19.94 | 2022 | |
| Shield Therapeutics INC | $16.60 | 2025 | |
| Amag Pharmaceuticals, INC. | $15.69 | 2020 | |
| Therapeuticsmd, INC. | $15.35 | 2019 | |
| Evofem Biosciences, INC. | $13.10 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.07 | 2019 | |
| Minerva Surgical, INC | $11.97 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Panesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.